ID   AE17-sOVA
AC   CVCL_LJ85
SY   AE17-secretory OVA
DR   Wikidata; Q54608903
RX   PubMed=14607902;
CC   Genetic integration: Method=Transfection; Gene=CGNC; 49631; OVAL/SERPINB14.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Transposon Tn5 neo.
CC   Transformant: ChEBI; CHEBI_46666; Crocidolite asbestos.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Breed/subspecies: C57BL/6J.
DI   NCIt; C21619; Mouse mesothelioma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4408 ! AE17
SX   Female
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
RX   PubMed=14607902; DOI=10.4049/jimmunol.171.10.5051;
RA   Jackaman C., Bundell C.S., Kinnear B.F., Smith A.M., Filion P.,
RA   van Hagen D., Robinson B.W.S., Nelson D.J.;
RT   "IL-2 intratumoral immunotherapy enhances CD8+ T cells that mediate
RT   destruction of tumor cells and tumor-associated vasculature: a novel
RT   mechanism for IL-2.";
RL   J. Immunol. 171:5051-5063(2003).
//